Figure 4From: PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with 177Lu-DOTA-bombesin analogues Influence of the amount of injected peptide on the biodistribution of 177 Lu-DOTA-PEG 5k -Lys-BN. Back to article page